Effects of phenethyl isothiocyanate and benzyl isothiocyanate, individually and in combination, on lung tumorigenesis induced in A/J mice by benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

Cancer Letters

Volumn 150, Issue 1, 2000, Pages 49-56

  Hecht, Stephen S ^a   Kenney, Patrick M J ^a   Wang, Mingyao ^a   Trushin, Neil ^b   Upadhyaya, Pramod ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

4 (Methylnitrosamino) 1 (3 pyridyl) 1 butanone; A J mice; Benzo a pyrene; Benzyl isothiocyanate; Chemoprevention; Lung tumors; Phenethyl isothiocyanate

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BENZO[A]PYRENE; BENZYL ISOTHIOCYANATE; PHENETHYL ISOTHIOCYANATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DIET; FEMALE; LUNG LAVAGE; LUNG TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOKING;

ANALYSIS OF VARIANCE; ANIMALS; ANTICARCINOGENIC AGENTS; BENZO(A)PYRENE; BODY WEIGHT; CARCINOGENS; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ISOTHIOCYANATES; LUNG NEOPLASMS; MICE; MICE, INBRED STRAINS; NITROSAMINES;

ANIMALIA; NICOTIANA TABACUM;

EID: 0034007594     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00373-0     Document Type: Article

References (23)

1. Hecht S.S. Approaches to chemoprevention of lung cancer based on carcinogens in tobacco smoke. Environ. Health Perspect. 105 (Suppl. 4):1997;955-963.
2. Wattenberg L.W., Wiedmann T.S., Estensen R.D., Zimmerman C.L., Steele V.E., Kelloff G.J. Chemoprevention of pulmonary carcinogenesis by aerosolized budenoside in female A/J mice. Cancer Res. 57:1997;5489-5492.
3. Kelloff G.J., Boone C.W., Crowell J.A., Steele V.E., Lubet R.A., Doody L.A., Malone W.F., Hawk E.T., Sigman C.C. New agents for cancer chemoprevention. J. Cell. Biochem. 265:1996;1-28.
4. You M., Bergman G. Preclinical and clinical models of lung cancer chemoprevention. Hematol. Oncol. Clinics N. Am. 12:1998;1037-1053.
5. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 91:1999;1194-1210.
6. National Cancer Institute, Chemoprevention Branch and Agent Development Committee, Clinical development plan: phenethyl isothiocyanate, J. Cell. Biochem. 265 (1996) 149-157.
7. S.S. Hecht, Chemoprevention by phytochemical modifers of carcinogen metabolism, in: Phytochemicals as Bioactive Agents, (1999) in press.
8. Adam-Rodwell G., Morse M.A., Stoner G.D. The effects of phenethyl isothiocyanate on benzo[a]pyrene-induced tumors and DNA adducts in A/J mouse lung. Cancer Lett. 71:1993;35-42.
9. Lin J.-M., Amin S., Trushin N., Hecht S.S. Effects of isothiocyanates on tumorigenesis by benzo[a]pyrene in murine tumor models. Cancer Lett. 74:1993;151-159.
10. Wattenberg L.W. Inhibitory effects of benzyl isothiocyanate administered shortly before diethylnitrosamine or benzo[a]pyrene on pulmonary and forestomach neoplasia in A/J mice. Carcinogenesis. 8:1987;1971-1973.
11. Hecht S.S., Isaacs S., Trushin N. Lung tumor induction in A/J mice by the tobacco smoke carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene: a potentially useful model for evaluation of chemopreventive agents. Carcinogenesis. 15:1994;2721-2725.
12. Hecht S.S., Lin D., Castonguay A. Effects of α-deuterium substitution on the mutagenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis. 4:1983;305-310.
13. Hecht S.S., Kenney P.M.J., Wang M., Trushin N., Agarwal S., Rao A.V., Upadhyaya P. Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol, and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Lett. 137:1999;123-130.
14. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc committee on the reformulation of the AIN-76A rodent diet. Am. Inst. Nutr. 1993;1939-1951.
15. Morse M.A., Reinhardt J.C., Amin S.G., Hecht S.S., Stoner G.D., Chung F.-L. Effect of dietary aromatic isothiocyanates fed subsequent to the administration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone on lung tumorigenicity in mice. Cancer Lett. 49:1990;225-230.
16. Hecht S.S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol. 11:1998;559-603.
17. El-Bayoumy K., Upadhyaya P., Desai D.H., Amin S., Hoffmann D., Wynder E.L. Effects of 1,4-phenylenebis(methylene)selenocyanate, phenethyl isothiocyanate, indole-3-carbinol, and d-limonene individually and in combination on the tumorigenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Anticancer Res. 16:1996;2709-2712.
18. Jiao D., Eklind K.I., Choi C.I., Desai D.H., Amin S.G., Chung F.L. Structure-activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Res. 54:1994;4327-4333.
19. Eklind K.I., Morse M.A., Chung F.-L. Distribution and metabolism of the natural anticarcinogen phenethyl isothiocyanate in A/J mice. Carcinogenesis. 11:1990;2033-2036.
20. Morse M.A., Eklind K.I., Toussaint M., Amin S.G., Chung F.-L. Characterization of a glucuronide metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. Carcinogenesis. 11:1990;1819-1823.
21. Heidelberger C., Weis S.M. The distribution of radioactivity in mice following administration of 3,4-benzpyrene-5-C14 and 1,2,5,6-dibenzanthracene-9,10-C14. Cancer Res. 11:1951;885-891.
22. Morse M.A., Eklind K.I., Amin S.G., Chung F.L. Effect of frequency of isothiocyanate administration on inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary adenoma formation in A/J mice. Cancer Lett. 62:1992;77-81.
23. Zhang Y., Talalay P. Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes. Cancer Res. 58:1998;4632-4639.